Delivery Order SPE2DX22D0010-SPE2D825FHV79
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,675.27 to AmerisourceBergen Drug Corp for the supply of Concerta HCL 18mg tablets (100 count) on July 31, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta 54mg tablets (100-count units) valued at $12,350.28 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Concerta ER (Extended Release) tablets 36 mg. This firm fixed-price delivery order, valued at approximately $42.9K, represents a non-competitive award under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. The contract is scheduled for completion by August 1, 2025, with fulfillment occurring at...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Concerta ER Tabs 27mg, a medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $34,825.79, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The contract will be fulfilled from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $2,021.76. This non-set-aside, competitively awarded contract operates under firm fixed pricing and is classified as a delivery order with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a contract ceiling value of $11,539.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,738.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. The contract, which is classified as a child order under a larger vehicle, carries an ultimate completion date of August 14, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHV79Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $31,857.38 to AmerisourceBergen Drug Corp for 36mg Concerta ER tablets on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates substantial experience fulfilling Defense Department pharmaceutical procurement requirements across multiple therapeutic domains, positioning the company as a key vendor for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.9k | 8/22/25 |